Table 5.
12-Month Treatment of DSM-IV/CIDI IED Among 6483 Adolescents in the NCS-A
| Characteristic | % (SE)
|
||
|---|---|---|---|
| 12-mo Treatmenta | 12-mo Treatment and Received Treatment for IED in the Past 12 mob | Patients Who Received Treatment for IED Among Those Who Had Received 12-mo Treatmentc | |
| Mental health specialty | 16.6 (3.3) | 6.0 (1.8) | 36.0 (10.1) |
| General medical | 9.3 (3.3) | 0.3 (0.2) | 3.5 (2.2) |
| School medication | 22.6 (4.2) | 4.6 (1.8) | 20.4 (7.6) |
| Any health care | 24.3 (4.0) | 6.1 (1.8) | 25.1 (6.6) |
| Human services | 10.2 (2.9) | 0.2 (0.1) | 1.6 (1.1) |
| Complementary/alternative medicine | 2.9 (1.2) | 1.5 (1.0) | 51.8 (20.7) |
| Juvenile justice | 0.6 (0.3) | 0.0 (0.0) | 0.0 (0.0) |
| Any treatment | 37.8 (3.6) | 6.5 (1.9) | 17.1 (5.0) |
Abbreviations: CIDI, Composite International Diagnostic Interview; IED, intermittent explosive disorder; NCS-A, National Comorbidity Survey Replication Adolescent Supplement.
a
Proportion of 12-mo cases that received treatment in the past year from the specified treatment sector.
b
Proportion of 12-mo cases that received treatment in the past year from the specified treatment sector and received treatment for IED.
c
Ratio of the first 2 columns, with the first column serving as the denominator.